|

Effectiveness of Pumpkin Seed Extract on Improving Blood Sugar Level in Subhealth Subjects

RECRUITINGN/ASponsored by Greenyn Biotechnology Co., Ltd.
Actively Recruiting
PhaseN/A
SponsorGreenyn Biotechnology Co., Ltd.
Started2023-03-01
Est. completion2024-09-30
Eligibility
Age20 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05738655

Summary

This randomized, double-blind, placebo-controlled, and parallel clinical study aims to investigate the effectivness of a pumpkin seed extract on blood sugar management in subhealth people.

Eligibility

Age: 20 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Fasting blood sugar levels from 100 to 125 mg/dL
* Glycated hemoglobin levels from 5.7 to 6.4%
* 2-hour OGTT levels from 140 to 199 mg/dL

Exclusion Criteria:

* Pregnant women or preparing for pregnancy.
* Lactating women.
* Women gave birth 6 months before the study.
* Poor kindy funciton
* Severe cardiovascular or other chronic diseases
* Patients with type I or II diabetes
* Poor compliance
* Alcohol abuser
* Using anti-diabetic or weight managent supplements
* Blood transfusion three months before the study
* Pumpkin seed allergy

Conditions2

DiabetesMetabolic Disease

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.